# Atopic Eczema in Adults

- Category: chronic
- Review status: reviewed (every claim checked against a document named on this page)
- Sources: Betamethasone Valerate 0.1%w/w Cream SmPC section 4.2 Posology and method of administration (eMC product 102491) · Eumovate (clobetasone butyrate 0.05%) Cream SmPC sections 4.2 and 4.4 (eMC product 3807) · Hydrocortisone 1% cream SmPC section 4.2 (eMC product 13103) · NICE CKS: Eczema - atopic 2025 · NICE Technology Appraisal TA82: Tacrolimus and Pimecrolimus for Atopic Eczema 2004 · No labelled dose - emollient applied liberally and as often as needed, to effect · Protopic 0.1% ointment SmPC sections 4.1 and 4.2 (eMC product 1608)
- Verified date: 2026-08

## Verified against

- Betamethasone Valerate 0.1%w/w Cream SmPC section 4.2 Posology and method of administration (eMC product 102491)
- Eumovate (clobetasone butyrate 0.05%) Cream SmPC sections 4.2 and 4.4 (eMC product 3807)
- Hydrocortisone 1% cream SmPC section 4.2 (eMC product 13103)
- No labelled dose - emollient applied liberally and as often as needed, to effect
- Protopic 0.1% ointment SmPC sections 4.1 and 4.2 (eMC product 1608)

## Treatment metadata

- Liquid paraffin — topical
- Hydrocortisone — topical
- Clobetasone — topical
- Betamethasone — topical
- Tacrolimus — topical

## Complete treatment card

```text
ATOPIC ECZEMA IN ADULTS
Sources: Betamethasone Valerate 0.1%w/w Cream SmPC section 4.2 Posology and method of administration
         (eMC product 102491) · Eumovate (clobetasone butyrate 0.05%) Cream SmPC sections 4.2 and
         4.4 (eMC product 3807) · Hydrocortisone 1% cream SmPC section 4.2 (eMC product 13103) ·
         NICE CKS: Eczema - atopic 2025 · NICE Technology Appraisal TA82: Tacrolimus and
         Pimecrolimus for Atopic Eczema 2004 · No labelled dose - emollient applied liberally and as
         often as needed, to effect · Protopic 0.1% ointment SmPC sections 4.1 and 4.2 (eMC product
         1608)
Review status: REVIEWED against 5 sources listed above  (2026-08)

IS IT THIS? - reference only, to read alongside your own examination
  SYMPTOMS - what the patient reports (3)
    - Itching severe enough to disturb sleep, with a history of the rash's onset and spread
      [itching · rash]
    - Personal or family history of atopic conditions such as asthma, hay fever or eczema  [allergic
      rhinitis]
    - Flares may be triggered by dust mites, animal dander, soaps, fragrances, synthetic fabrics,
      sweating or certain foods  [sweating]
  SIGNS - what you find (5)
    - Adults typically show thickened, lichenified plaques with exaggerated skin lines, often on the
      hands  [plaques]
    - In the acute stage, lesions are swollen red papules and plaques that may weep or crust
      [papules · plaques]
    - Subacute lesions show redness, scaling and variable crusting  [crusting · redness · scaling]
    - Chronic lesions are thick plaques with lichenification and scale  [plaques]
    - Keratosis pilaris may be an associated finding supporting the diagnosis
  TESTS (3)
    - Diagnosis is usually made clinically from the typical presentation, without routine testing
    - A skin biopsy, if done, typically shows an eczematous pattern
    - In hard-to-treat pediatric cases, IgE testing by immunoassay or skin prick may look for
      specific allergens
  IF NOT THIS - what else fits (4)
    - Allergic contact dermatitis rather than atopic disease
    - Lichen simplex or lichen planus
    - Psoriasis, scabies, or a fungal (tinea) infection
    - Seborrheic dermatitis, a distinct scaly rash
  Source  StatPearls "Atopic Dermatitis" - disease-level clinical article
  Status  traced to the source above

Rx: Emollient - use throughout  |  Topical steroid - face and flexures  |  Topical steroid - trunk
    and limbs  |  Topical steroid - potent, short flare  |  Steroid-sparing alternative

EMOLLIENT - USE THROUGHOUT
1. LIQUID PARAFFIN                                        [1st line]
   Adult    Apply emollient liberally and frequently (at least 2-3 times daily) to all skin,
            including areas that are currently clear - long-term continuous maintenance
   Peds     Not applicable in this adult entry - see 'Atopic Eczema in Children' for paediatric
            dosing
   Source   No labelled dose - emollient applied liberally and as often as needed, to effect
   Why      Emollients remain the foundation of adult eczema management and reduce the amount of
            topical corticosteroid needed
   Caution  Continue emollient use even when skin is clear to maintain barrier function.
            Apply emollient 15-30 minutes before or after a topical steroid, not at the same time.
            Warn about fire hazard when fabric contacts paraffin-based products.
            Use a soap substitute rather than standard soap.
   Egypt    ADCOCARE CREAM 20 GM             ARAB DRUG COM...    12.00 EGP
                -> ! also contains glyceryl monostearate, propylene glycol, urea
            DERMOLAN CREAM 50 GM             HI-CARE > EMI...    19.00 EGP
                -> ! also contains allantoin, glycerol, glycolic acid, panthenol, salicylic acid,
                   urea, vitamin c, zinc oxide
            ADCOCARE CREAM 40 GM             ARAB DRUG COM...    21.75 EGP
                -> ! also contains glyceryl monostearate, propylene glycol, urea
            CARE MIX PLUS HAIR CREAM 50 GM   VITA PHARM > ...    29.50 EGP
                -> ! also contains cetostearyl alcohol, lanolin, panthenol, wheat protein, white
                   soft paraffin
            PROPOLIS CREAM 15 ML             LUNA FOR PERF...    30.00 EGP
                -> ! also contains cera alba, glycerin, propolis
            PROPOLIS CREAM 30 ML             LUNA FOR PERF...    55.00 EGP
                -> ! also contains cera alba, glycerin, propolis
            HEALTHPOINT NAPPY CREAM 100 GM   HEALTHPOINT L...    70.00 EGP
                -> ! also contains benzyl alcohol, cetearyl alcohol, glyceryl stearate, lanolin,
                   peg-100 s, water, zinc oxide
            HERCUL WHITENING CREAM 60 GM     LEADER FOR CO...    74.75 EGP
                -> ! also contains alpha arbutin, diemthicone, glycerin, licorice ext, octyl
                   methoxy, titanium dioxide, vit.c


TOPICAL STEROID - FACE AND FLEXURES
2. HYDROCORTISONE                                         [1st line]
   Adult    Adults and children: To be applied sparingly to the affected skin two or three times
            daily after gently cleansing the area. x up to 1-2 weeks, then reassess. The label does
            not set a number for the face beyond avoiding prolonged use - keep facial courses as
            short as the flare allows
   Peds     Not applicable in this adult entry - see 'Atopic Eczema in Children' for paediatric
            dosing
   Source   Hydrocortisone 1% cream SmPC section 4.2 (eMC product 13103)
   Why      Mild potency is reserved for delicate facial and flexural skin; step up to moderate
            potency for the trunk and limbs if inadequate response
   Caution  Avoid prolonged use on the face - the label says so without naming a number, so the
            five-day figure often quoted is custom rather than licence. Shortest course that settles
            it.
            Stop once the flare resolves; do not use as long-term continuous maintenance.
            Watch for secondary bacterial infection (weeping, crusting, pustules) requiring oral
            flucloxacillin.
            Limit a course in a child to 7-10 days, and remember the face and scalp absorb far more
            than limb skin.
            Hydrocortisone Cream is contra-indicated in patients with bacterial, viral or fungal
            infections of the skin. Urticaria, rosacea, ulcers and local infection are also contra-
            indications.
   Egypt    NOVACORTIN 1% CREAM 15 GM        PHAROPHARMA          4.75 EGP
            NOVACORTIN 1% OINT. 15 GM        PHAROPHARMA          4.75 EGP
            MICORT 1% CREAM 20 GM            MISR                12.50 EGP
            HYDROCORTISONE 1% OINT. 20 GM    MISR                21.00 EGP


TOPICAL STEROID - TRUNK AND LIMBS
3. CLOBETASONE                                            [1st line]
   Adult    Apply 0.05% cream/ointment thinly once or twice daily to inflamed skin on the trunk and
            limbs - Up to 4 weeks of continuous daily use; a child should not normally exceed 7 days
   Peds     Not applicable in this adult entry - see 'Atopic Eczema in Children' for paediatric
            dosing
   Source   Eumovate (clobetasone butyrate 0.05%) Cream SmPC sections 4.2 and 4.4 (eMC product 3807)
   Why      Moderate potency for trunk/limb flares not controlled by mild potency steroid, per the
            CKS potency ladder
   Caution  Do not use on the face or flexures - reserve moderate potency for the trunk and limbs.
            There is a risk of skin thinning (atrophy) with prolonged or repeated courses.
            Four weeks of continuous daily use is the adult ceiling. In a child it is normally seven
            days, and under 12 it should be a doctor's decision to use it at all.
            Keep it off the face where you can - facial skin thins faster than anywhere else.
            Under a dressing it absorbs far more and the warm damp underneath breeds bacteria. Clean
            the skin before each fresh dressing.
   Egypt    EUMOVATE 0.05% TOP. CREAM 15 GM  GLAXO SMITHKLINE    12.75 EGP
            EUMOVATE 0.05% TOP. OINT. 15 GM  SMITHKLINE BE...    12.75 EGP


TOPICAL STEROID - POTENT, SHORT FLARE
4. BETAMETHASONE                                          [2nd line]
   Adult    Apply 0.1% cream/ointment thinly twice daily to affected areas for itch and inflammation
            - Short courses during a flare, usually 1-2 weeks; step back down once the flare settles
   Peds     This entry is for adults. In a child, a potent steroid on the trunk or limbs is a short,
            deliberate course - see the childhood eczema entry, and never use a potent steroid on a
            child's face or flexures.
   Source   Betamethasone Valerate 0.1%w/w Cream SmPC section 4.2 Posology and method of
            administration (eMC product 102491)
   Why      The potent rung the ladder was missing. Hydrocortisone 1% is mild and clobetasone 0.05%
            moderate; when a trunk or limb flare does not settle on clobetasone the next step is a
            potent steroid, not a calcineurin inhibitor. Undertreating a flare with a steroid too
            weak for it is the commoner failure in eczema, not overtreating.
   Caution  Potent steroid. Not on the face, the eyelids or the flexures - use hydrocortisone 1%
            there. Potent steroid on facial skin thins it and causes perioral dermatitis.
            Short courses during a flare, then step back down. Continuous potent steroid causes skin
            atrophy, striae that do not recover, and telangiectasia.
            Fingertip units, not 'a thin smear'. Undertreating a flare is what makes people believe
            steroids do not work and then use them for longer.
            Do not apply to infected or ulcerated skin. Weeping, crusted or rapidly worsening eczema
            is usually infected and needs that treated first.
            Keep the emollient going underneath and between flares. The steroid treats the flare;
            the emollient is what reduces how often flares come.
   Egypt    CRONOMESONE 0.1% CREAM 15 GM     PHAROPHARMA          4.00 EGP
            CRONOMESONE 0.1% OINT. 15 GM     PHAROPHARMA          4.00 EGP
            BETNOVATE 0.1% TOP. OINT. 15 GM  SMITHKLINE BE...     6.90 EGP
            BETADERM 0.1% CREAM 15 GM        EIPICO              18.00 EGP
            BETAVAL 0.1% CREAM 20 GM         ARAB DRUG COM...    20.00 EGP
            BETADERM 0.1% CREAM 30 GM        EIPICO              23.00 EGP
            BETAMETHASONE DIPROPIONATE 0.05% CREAM 20 GM AMRIYA                            11.50 EGP
            BETAMETHASONE DIPROPIONATE 0.05% OINT. 20 GM AMRIYA                            11.50 EGP


STEROID-SPARING ALTERNATIVE
5. TACROLIMUS                                             [2nd line]
   Adult    Apply 0.1% ointment thinly twice daily to affected areas (the 0.1% strength is licensed
            for adults only; children use 0.03%) - until lesions clear, then maintenance once a day
            twice weekly; eligibility for maintenance is a response within 6 weeks of twice-daily
            use
   Peds     Not applicable in this adult entry - see 'Atopic Eczema in Children' for paediatric
            dosing
   Source   Protopic 0.1% ointment SmPC sections 4.1 and 4.2 (eMC product 1608)
   Why      Second-line, steroid-sparing option for moderate-to-severe eczema not controlled by
            topical corticosteroids, or where continued steroid use risks skin atrophy, particularly
            on the face; TA82 recommends initiation only by a clinician with dermatology experience
   Caution  Not first-line and not for mild eczema - reserve for moderate-to-severe disease
            unresponsive to topical corticosteroids.
            Transient burning or stinging on application is common and usually settles within a few
            days.
            Avoid sun exposure and use sun protection on treated skin.
            Avoid occlusive dressings over application sites.
            Reconsider the diagnosis and the treatment if there is no improvement after two weeks of
            twice-daily use.
            A patient on maintenance needs a physician review at 12 months to decide whether to
            continue.
   Egypt    TAROLIMUS 0.1% TOPICAL OINT. 15 GM ANDALOUS PHARMA                            144.00 EGP
            TRECZIMUS 0.1% TOPICAL OINT. 30 GM MARCYRL PHARMACEUTICAL INDUSTRIES (MPI)    219.00 EGP
            PROTOPIC 0.1 % OINT. 30 GM       LEO PHARMACEU...   407.00 EGP
            TRECZIMUS 0.03% TOPICAL OINT. 20 GM MARCYRL PHARMACEUTICAL INDUSTRIES (MPI)   114.00 EGP
            TAROLIMUS 0.03% TOPICAL OINT. 15 GM ANDALOUS PHARMA                           129.00 EGP
            PROTOPIC 0.03 % OINT. 30 GM      LEO PHARMACEU...   371.00 EGP

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.
```

---

Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement.

[Privacy policy](/privacy)
